<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="30249">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02090517</url>
  </required_header>
  <id_info>
    <org_study_id>430519</org_study_id>
    <secondary_id>430519</secondary_id>
    <nct_id>NCT02090517</nct_id>
  </id_info>
  <brief_title>Laser Therapy Versus Electrosurgery For Nasal Telangiectasias</brief_title>
  <official_title>Evaluation of Laser Therapy Vs Electrosurgery For Nasal Telangiectasias Using A Novel Vascular Imaging Device</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Davis</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, Davis</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to compare the efficacy of various treatment options for
      eliminating nasal telangiectasias. The study will compare the outcome of treating nasal
      telangiectasias with the following; no treatment (control site), alexandrite laser, pulsed
      dye laser, combination pulsed dye laser and Nd:YAG 1064nm multiplex laser system and
      electrosurgery.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Anticipated">March 2015</completion_date>
  <primary_completion_date type="Anticipated">March 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Open Label, Primary Purpose: Supportive Care</study_design>
  <primary_outcome>
    <measure>Reduction of Area of Nasal Telangiectasias by Laser Therapy Vs Electrosurgery</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>The study will measure the changes in length and width (area) of nasal telangiectasias  before and after treatment with the following: no treatment (control site), alexandrite laser, pulsed dye laser, combination pulsed dye laser and Nd:YAG 1064nm multiplex laser system and electrosurgery.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluation of Cosmetic Improvement</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Percent perceived improvement for nasal vessels by the patient via questionnaire.</description>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Telangiectasis</condition>
  <arm_group>
    <arm_group_label>Pulsed Dye Laser</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects with multiple nose telangiectasias will be enrolled. One nose telangiectasia (of 5) will be treated with pulsed dye laser.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Long Pulsed Alexandrite Laser</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects with multiple nose telangiectasias will be enrolled. One nose telangiectasia (of 5) will be treated with long pulsed alexandrite laser.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pulsed Dye Laser Plus Nd:YAG Laser</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects with multiple nose telangiectasias will be enrolled. One nose telangiectasia (of 5) will be treated with pulsed dye laser plus Nd:YAG laser.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Electrodesiccation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects with multiple nose telangiectasias will be enrolled. One nose telangiectasia (of 5) will be treated with electrodesiccation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No Treatment</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Subjects with multiple nose telangiectasias will be enrolled. One nose telangiectasia (of 5) will receive no treatment.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Pulsed Dye Laser</intervention_name>
    <description>Pulsed dye laser treatments will be performed with a 595 nanometer wavelength, 20 millisecond pulse duration, at 10 Joules/cm2, with a 10 millimeter spot size.</description>
    <arm_group_label>Pulsed Dye Laser</arm_group_label>
    <other_name>Pulsed dye laser treatments will be performed with a 595 nanometer wavelength, 20 millisecond pulse duration, at 10 Joules/cm2, with a 10 millimeter spot size.</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Long Pulsed Alexandrite Laser</intervention_name>
    <description>Alexandrite laser will be used with a 755 nanometer wavelength, 40 millisecond pulse duration, at 88Joules/cm2, with a 6 millimeter spot size.</description>
    <arm_group_label>Long Pulsed Alexandrite Laser</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Pulsed Dye Laser Plus Nd:YAG Laser</intervention_name>
    <description>The Cynergy with MultiPlex will be used with a multiplex mode system with a pulse dye laser at 585 nanometer wavelength, 20 milliseconds pulse duration, at 7 Joules/cm2 with a 7 millimeter spot size, with a short delay, followed by a Nd:YAG 1064 nanometer wavelength, 20 millisecond pulse duration, at 50 Joules/cm2 with a 7 millimeter spot size.</description>
    <arm_group_label>Pulsed Dye Laser Plus Nd:YAG Laser</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Electrodesiccation</intervention_name>
    <description>A curette is used to scrape off the cancer down to the dermis. The scraping is then paused while an electrosurgical device like a hyfrecator is used next. Electrodesiccation is performed over the raw surgical ulcer to denature a layer of the dermis and the curette is used again over the surgical ulcer to remove denatured dermis down to living tissue.</description>
    <arm_group_label>Electrodesiccation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Over 18 years of age

          -  Able to give informed consent themselves

          -  Willing to return for follow up visit

          -  0.5 - 3 millimeter Vessel size

          -  5 Non-contiguous nasal vascular lesions

        Exclusion Criteria:

          -  Mentally handicapped

          -  Unable to understand written and oral English

          -  Incarceration

          -  Under 18 years of age

          -  Unwilling to return for follow up

          -  Pregnant Women

          -  Vessels less than 0.5 millimeter caliber

          -  Less than 5 non-contiguous vessels
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daniel Eisen, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, Davis</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Daniel Eisen, M.D.</last_name>
    <phone>916-734-6479</phone>
    <email>daniel.eisen@ucdmc.ucdavis.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lam Nguyen</last_name>
    <phone>916-734-6556</phone>
    <email>lam.nguyen@ucdmc.ucdavis.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of California-Davis, Department of Dermatology</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95816</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel Eisen, M.D.</last_name>
      <phone>916-734-6479</phone>
      <email>daniel.eisen@ucdmc.ucdavis.edu</email>
    </contact>
    <contact_backup>
      <last_name>Lam Nguyen</last_name>
      <phone>916-734-6556</phone>
      <email>lam.nguyen@ucdmc.ucdavis.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Daniel Eisen, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.ucdmc.ucdavis.edu/dermatology/clinical_research</url>
    <description>University of California-Davis Department of Dermatology Clinical Research</description>
  </link>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 14, 2014</lastchanged_date>
  <firstreceived_date>December 4, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Nasal telangiectasis</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Telangiectasis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
